Last October, a research report by Research2Guidance showed that although the pharmaceutical giant developed a lot of apps, the download volume was not satisfactory. The survey sample was taken from 725 APPs from 11 globally renowned pharmaceutical companies (see below). In August of this year, the latest survey from German APP company SmartPatient found that 66% of the apps developed by pharmaceutical companies were distributed in the developed countries of the United States, the United Kingdom and Germany.
It can be seen that the general public on a global scale still feels unfamiliar with Internet medical care and is far from forming a habit. In the cardiovascular field, overseas famous pharmaceutical companies are still taking the lead in the development of smart hardware, wearable devices and APP, while domestic traditional pharmaceutical companies have not performed any performance.
Merk
On August 22, 2014, Merk acquired eCardio. eCardio can provide a variety of ECG monitoring equipment to help doctors improve the diagnosis of arrhythmia and other symptoms. Its remote diagnostics service is also used on heart rate monitoring devices that connect Alivecor to smartphones. On September 9, 2014, eCardio merged with wearables and remote monitoring equipment manufacturer Preventice, and Merk Global Health Innovation Fund (Merk GHI) funded the development of Preventice's BodyGuardian heart rate sensor.
On October 7, 2013, Merk GHI acquired Omnio, an Internet health company. The acquisition means acquiring Omnio's iPad app, a tool that provides medical personnel with quick and easy access to medical information. It contains medical guidance for heart disease atrial fibrillation.
Astrazeneca
On July 14, 2015, Astrazeneca and Vida Health wanted to jointly develop an APP that would help patients with a first heart attack recover. The APP is named Day-By-Day, which complies with the HIPAA confidentiality agreement and is first tested at Duke University to help patients change their lifestyle and take medication according to digital education guidelines such as videos, articles, dietary advice, etc. The first attack occurred in a second heart attack. It is also a content extension of Vida Health's existing mobile app about chronic disease self-health management.
Astrazeneca has also developed medical education tools that allow doctors to show patients the shape of atherosclerosis in an animated form, facilitating patient-to-patient discussion. The patient's LDL, HDL, and triglyceride values ​​can be entered and the snapshot image of any stage can be emailed to the patient via the reporting function.
Pfizer
On May 24, 2012, Pfizer and EatingWell magazine collaborated to develop an app for hyperlipidemic patients. The APP is only for patients taking the lipid-lowering drug Lipitor, including EatWell magazine's shopping list tool, regular cooking tools and recipe query tools, and Lipitor's $4 co-payment card. But the good times are not long, this app will soon be removed.
Pfizer also develops an app for a healthy little secretary. It is a health gadget that records all the indicators. It can record BMI, weight, blood pressure, heart rate, blood sugar, allergy records, etc. It can also set medication reminders and hospital searches. , common disease inquiries, etc.
Ostomy Bags Accessories,Ostomy Bag Accessories,Colostomy Bag Accessories,Stoma Bag Accessories
Henan Maidingkang Medical Technology Co.,Ltd , https://www.mdkmedicales.com